Submit an Article
Navigate
Home
Editorial Board
Editorial Policies
Current Volume
Archive
Scientific Integrity
Publication Ethics Statements
Interviews with Outstanding Authors
Newsroom
Sponsored Conferences
Podcast
Contact
Special Collections
Submit an Article
Online ISSN: 1945-4589
Research Paper
|
Volume 16, Issue 3
|
pp. 2812–2827
Construction of a necroptosis-related lncRNA signature for predicting prognosis and revealing the immune microenvironment in bladder cancer
Back to article
Figure 9
(9 of 10)
−
100%
+
Figure 9.
Chemotherapy drug sensitivity.
(
A
–
F
) IC50 of several chemotherapy drugs in BC. (
A
) Alisertib; (
B
) Buparlisib; (
C
) Dasatinib; (
D
) Cisplatin; (
E
) Sorafenib; (
F
) EPZ5676.
